Results 11 to 20 of about 6,523 (214)
Neonatal Alloimmune Thrombocytopenia [PDF]
Neonatal alloimmune thrombocytopenia is the most common cause of immune-mediated thrombocytopenia in the newborn period. The disorder results from placental transfer of maternal alloantibodies directed against paternally inherited antigens carried on fetal platelets. While most cases are mild, some neonates have very low platelet counts associated with
J, Roganović+3 more
openaire +2 more sources
Introduction. The risk of developing transfusion-related complications, especially alloimmunization, is an ongoing concern for transfusion-dependent patients.
Fahd A. Kuriri+5 more
doaj +1 more source
Alloimmunization to red cell antigens is a taxing complication of thalassemia major and intermedia patients who receive routine blood transfusions. The data on alloimmunization in beta-thalassemia are sparse from developing countries.
Satyam Arora+3 more
doaj +1 more source
Alloimmunization is currently the most frequent adverse blood transfusion event. Whilst completely matched donor blood would nullify the alloimmunization risk, this is practically infeasible.
Joost H. J. van Sambeeck+16 more
doaj +1 more source
Red blood cell alloimmunization in Iran: A Comprehensive review of the literature
Background: Alloimmunization is an immune response against foreign antigens which introduced into the body through transfusion, pregnancy, or transplantation. This phenomenon is a big challenge in patients, which require regular transfusions.
Maryam Sadat Hosseini+3 more
doaj +1 more source
Introduction The alloimmunization following blood transfusion can be life‐threatening. The Rh alloantibodies are one of the most common causes contributing to alloimmunization.
Mohammad Ali Jalali Far+4 more
doaj +1 more source
Crossmatch: Alloimmunization versus unspecific agglutination reactions?
Journal of Veterinary Internal Medicine, Volume 37, Issue 1, Page 8-9, January/February 2023.
Urs Giger
wiley +1 more source
Impact of hyperlipidemia on alloimmunity [PDF]
Hyperlipidemia is a comorbidity affecting a significant number of transplant patients despite treatment with cholesterol lowering drugs. Recently, it has been shown that hyperlipidemia can significantly alter T-cell responses to cardiac allografts in mice, and graft rejection is accelerated in dyslipidemic mice.
Jin Yuan, John Iacomini, Jessamyn Bagley
openaire +2 more sources
Platelet transfusion can elicit alloimmune responses leading to alloantibody formation against donor-specific polymorphic residues, ultimately resulting in platelet transfusion refractoriness.
Anno Saris+10 more
doaj +1 more source
Journal of Veterinary Internal Medicine, Volume 37, Issue 1, Page 10-11, January/February 2023.
Lisa Herter+5 more
wiley +1 more source